There was wording I did like. It looks like they stopped saying they "might" up list and will do it. If they get all the patents I think the price will get up there for a smaller reverse split, maybe 1 for 10. That's going off the belief that they need a price of $4 per share to list with Nasdaq. Next month should give decent insight on a possible timeline.
A new investor would be nice to see. I do not want to see more money from same company.
(2)
(0)
Propanc Biopharma, Inc. (PPCB) Stock Research Links